Disclaimer | LogIn     
1546-2080 Online :: 1546-203X Print
Strategies for Licensing, Developing, Commercializing and Financing Nanotechnology
Volume 2, Issue 4

Jeff Stewart, Arnall Golden Gregory LLP

The current commercial path for nanotechnology ventures mirrors the early evolution of the biotechnology industry, allowing similar strategies toward technology commercialization and investment opportunities.  While this premise rings true for the most part, there are some important differences between the commercial paths of nanotechnology ventures and ventures in the biotechnology industry.  In this article, Jeff Stewart outlines strategies for licensing, developing, commercializing and financing nanotechnology.  By comparing the experiences of university biotechnology spinout companies  to spinouts in the nanotechnology context, Stewart offers some empirical lessons for dealing with the nanotechnology university spinout company.  Particular attention is paid to licensing agreements, the role of the university nanotechnology scientist in the process, financing and product strategies.

Full Text (PDF)
Home   :   Aims & Scope    :   Editorial Board    :   Subscriptions   :   Partnerships  :   Contact Us
Nanotechnology Law & Business Copyright 2005